The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Mortality in early inflammatory polyarthritis: Cardiovascular mortality is increased in seropositive patients
Abstract
Objective: To determine the degree and causes of any excess mortality observed during the early years of inflammatory polyarthritis (IP). Methods: Between 1990 and 1994, a total of 1,236 patients were registered with the Norfolk Arthritis Register, a primary care–based inception cohort. All patients were tracked on the National Health Service Central Register for notification of death. The vital status of each patient was determined as of December 31, 1999. Causes of death were coded according to the International Classification of Diseases, Ninth Revision. Expected death rates were calculated using annual death rates for the Norfolk population. Standardized mortality ratios (SMRs) were calculated for all IP patients and for the subgroups of patients who did and did not satisfy the American College of Rheumatology (ACR) 1987 criteria for rheumatoid arthritis (RA) at baseline, as well as for the subgroups who were and were not rheumatoid factor (RF) positive at baseline. Results: By December 31, 1999, 160 patients (13%; 79 women and 81 men) had died. The median duration of followup in the entire cohort was 6.9 years. Mortality rates were not significantly increased in the entire group of patients with IP or in the subgroup who met the ACR 1987 criteria for RA at baseline. In contrast, RF‐positive patients had an increased rate of death from all causes (SMR in men 1.51, in women 1.41). Cardiovascular disease was the most common cause of death. The majority of the excess mortality in the RF‐positive patients could be attributed to cardiovascular causes (SMR in men 1.34, in women 2.02). Conclusion: Excess mortality in the early years of IP is confined to patients who are seropositive for RF. While excess cardiovascular mortality has been described in patients with established RA, this is the first report of premature death from heart disease in the early years of IP.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
(1990) · Choice Reviews Online · doi:10.5860/choice.27-3338 · Cited by 35,305
Arnett, F. C., Edworthy, S. M., Bloch, D. A., Mcshane, D. J., Fries, J. F., Cooper, N. S., Healey, L. A., Kaplan, S. R., Liang, M. H., Luthra, H. S., et al. (1988) · Arthritis & Rheumatism · doi:10.1002/art.1780310302 · Cited by 19,752
- STATISTICAL PACKAGE FOR SOCIAL SCIENCES
(2014) · Statistical Methods in Psychiatry Research and SPSS · doi:10.1201/b17560-26 · Cited by 12,056
Revised Criteria for the Classification of Rheumatoid Arthritis
Arnett, F. C. (1990) · Orthopaedic Nursing · doi:10.1097/00006416-199003000-00011 · Cited by 7,723
Ridker, P. M., Hennekens, C. H., Buring, J. E., & Rifai, N. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003233421202 · Cited by 5,850
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., & Hennekens, C. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361401 · Cited by 5,504
Koenig, W., Sund, M., Fröhlich, M., Fischer, H.-G., Löwel, H., Döring, A., Hutchinson, W. L., & Pepys, M. B. (1999) · Circulation · doi:10.1161/01.cir.99.2.237 · Cited by 1,964
Risk of Cardiovascular Events Associated with Selective COX-2 Inhibitors
Mukherjee, D. (2001) · JAMA · doi:10.1001/jama.286.8.954 · Cited by 1,741
Cardiovascular Medicine at the Turn of the Millennium: Triumphs, Concerns, and Opportunities
Braunwald, E. (1997) · New England Journal of Medicine · doi:10.1056/nejm199711063371906 · Cited by 1,424
The mortality of rheumatoid arthritis
Wolfe, F., Mitchell, D. M., Sibley, J. T., Fries, J. F., Bloch, D. A., Williams, C. A., Spitz, P. W., Haga, M., Kleinheksel, S. M., & Cathey, M. A. (1994) · Arthritis & Rheumatism · doi:10.1002/art.1780370408 · Cited by 1,310
Relation of C-Reactive Protein and Coronary Heart Disease in the MRFIT Nested Case-Control Study
for the MRFIT Research Group, Kuller, L. H., Tracy, R. P., Shaten, J., & Meilahn, E. N. (1996) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a008963 · Cited by 1,097
Fibrinogen as a Cardiovascular Risk Factor: A Meta-Analysis and Review of the Literature
Ernst, E., & Resch, K. L. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-118-12-199306150-00008 · Cited by 990
Pincus, T., Callahan, L. F., Sale, W. G., Brooks, A. L., Payne, L. E., & Vaughn, W. K. (1984) · Arthritis & Rheumatism · doi:10.1002/art.1780270805 · Cited by 760
KIRWAN, J. R., & REEBACK, J. S. (1986) · Rheumatology · doi:10.1093/rheumatology/25.2.206 · Cited by 488
SYMMONS, D. P. M., BARRETT, E. M., BANKHEAD, C. R., SCOTT, D. G. L., & SILMAN, A. J. (1994) · Rheumatology · doi:10.1093/rheumatology/33.8.735 · Cited by 464
Self-citationSurvival, prognosis, and causes of death in rheumatoid arthritis
Mitchell, D. M., Spitz, P. W., Young, D. Y., Bloch, D. A., McShane, D. J., & Fries, J. F. (1986) · Arthritis & Rheumatism · doi:10.1002/art.1780290602 · Cited by 431
Wållberg‐Jonsson, S., Ohman, M. L., & Dahlqvist, S. R. (1997) · PubMed · Cited by 417
Wållberg‐Jonsson, S., Johansson, H., Ohman, M. L., & Rantapää‐Dahlqvist, S. (1999) · PubMed · Cited by 409
LINOS, A., WORTHINGTON, J. W., O'FALLON, M., & KURLAND, L. T. (1980) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112878 · Cited by 403
A Tale of Two Diseases: Atherosclerosis and Rheumatoid Arthritis
Pasceri, V., & Yeh, E. T. H. (1999) · Circulation · doi:10.1161/01.cir.100.21.2124 · Cited by 377
Symmons, D. P. M., Jones, M., Scott, D. L., & Prior, P. (1998) · PubMed · Cited by 319
Self-citationHomocysteine and Risk of Cardiovascular Disease Among Postmenopausal Women
Ridker, P. M. (1999) · JAMA · doi:10.1001/jama.281.19.1817 · Cited by 253
CAUSE OF DEATH IN RHEUMATOID ARTHRITIS
PRIOR, P., SYMMONS, D. P. M., SCOTT, D. L., BROWN, R., & HAWKINS, C. F. (1984) · Rheumatology · doi:10.1093/rheumatology/23.2.92 · Cited by 247
Self-citationHaagsma, C. J., Blom, H. J., van Riel, P. L. C. M., van't Hof, M. A., Giesendorf, B. A. J., van Oppenraaij-Emmerzaal, D., & van de Putte, L. B. A. (1999) · Annals of the Rheumatic Diseases · doi:10.1136/ard.58.2.79 · Cited by 207
Mortality and survival in rheumatoid arthritis: a 25 year prospective study of 100 patients.
Reilly, P. A., Cosh, J. A., Maddison, P. J., Rasker, J. J., & Silman, A. J. (1990) · Annals of the Rheumatic Diseases · doi:10.1136/ard.49.6.363 · Cited by 205
Self-citationThe effect of smoking on clinical, laboratory, and radiographic status in rheumatoid arthritis.
Wolfe, F. (2000) · PubMed · Cited by 204
Abnormal homocysteine metabolism in rheumatoid arthritis
Roubenoff, R., Dellaripa, P., Nadeau, M. R., Abad, L. W., Muldoon, B. A., Selhub, J., & Rosenberg, I. H. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400418 · Cited by 176
Novel Risk Factors for Atherosclerosis
Kullo, I. J., Gau, G. T., & Tajik, A. J. (2000) · Mayo Clinic Proceedings · doi:10.4065/75.4.369 · Cited by 161
Morgan, S. L., Baggott, J. E., Lee, J. Y., & Alarcón, G. S. (1998) · PubMed · Cited by 155
Cardiovascular mortality in women with rheumatoid arthritis.
Myllykangas-Luosujärvi, R., Aho, K., Kautiainen, H., et al. (1995) · PubMed · Cited by 155
Estimating the incidence of rheumatoid arthritis: Trying to hit a moving target?
Wiles, N., Symmons, D. P. M., Harrison, B., Barrett, E. M., Barrett, J. H., Scott, D. G. I., & Silman, A. J. (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199907)42:7<1339::aid-anr6>3.0.co;2-y · Cited by 148
Self-citationKroot, E.-J. J. A., van Leeuwen, M. A., van Rijswijk, M. H., Prevoo, M. L. L., Hof, M. A. V. '., van de Putte, L. B. A., & van Riel, P. L. C. M. (2000) · Annals of the Rheumatic Diseases · doi:10.1136/ard.59.12.954 · Cited by 141
Outcome of rheumatoid arthritis in relation to age and rheumatoid factor at diagnosis.
van Schaardenburg, D., Hazes, J. M. W., de Boer, A., Zwinderman, A. H., Meijers, K. A. E., & Breedveld, F. C. (1993) · PubMed · Cited by 106
Mortality in a cohort of Norwegian patients with rheumatoid arthritis followed from 1977 to 1992
Kvalvik, A. G. (2000) · Scandinavian Journal of Rheumatology · doi:10.1080/030097400750001770 · Cited by 103
Dyslipidaemia and rheumatoid arthritis
Situnayake, R. D., & Kitas, G. D. (1997) · Annals of the Rheumatic Diseases · doi:10.1136/ard.56.6.341 · Cited by 87
Komuro (2001) · doi:10.1002/1529-0131(200112)44:12
Cited by
Aviña‐Zubieta, J. A., Choi, H. K., Sadatsafavi, M., Etminan, M., Esdaile, J. M., & Lacaille, D. (2008) · Arthritis Care & Research · doi:10.1002/art.24092 · Cited by 1,462
Agca, R., Heslinga, S. C., Rollefstad, S., Heslinga, M., McInnes, I. B., Peters, M. J. L., Kvien, T. K., Dougados, M., Radner, H., Atzeni, F., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-209775 · Cited by 1,380
Self-citationThe global burden of rheumatoid arthritis: estimates from the Global Burden of Disease 2010 study
Cross, M., Smith, E., Hoy, D., Carmona, L., Wolfe, F., Vos, T., Williams, B., Gabriel, S., Lassere, M., Johns, N., et al. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204627 · Cited by 1,153
Avina-Zubieta, J. A., Thomas, J., Sadatsafavi, M., Lehman, A. J., & Lacaille, D. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-200726 · Cited by 945
Cardiovascular death in rheumatoid arthritis: A population‐based study
Maradit‐Kremers, H., Nicola, P. J., Crowson, C. S., Ballman, K. V., & Gabriel, S. E. (2005) · Arthritis & Rheumatism · doi:10.1002/art.20878 · Cited by 934
Metadata
- Authors
- Goodson, N. J., Wiles, N. J., Lunt, M., Barrett, E. M., Silman, A. J., & Symmons, D. P. M.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 2002-08
- Volume
- 46
- Issue
- 8
- Pages
- 2010-2019
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W1984520299
- Cited by
- 366
- References
- 37
- FWCI
- 12.17
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.